Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Personalis Community
NasdaqGM:PSNL Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Personalis
Popular
Undervalued
Overvalued
Community Investing Ideas
Personalis
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
NeXT Personal Testing And Moderna Partnership Will Improve Cancer Care
Key Takeaways Strategic partnerships and agreements are expected to drive significant revenue and market expansion, particularly in MRD testing and tumor profiling. Investments and collaborations with major companies should enhance distribution and efficiency, improving revenue and margins through economies of scale.
View narrative
US$7.33
FV
55.3% undervalued
intrinsic discount
20.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
PSNL
PSNL
Personalis
Your Fair Value
US$
Current Price
US$3.28
29.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-113m
220m
2015
2018
2021
2024
2025
2027
2030
Revenue US$219.9m
Earnings US$27.2m
Advanced
Set Fair Value